Back to search

Article

Amisulpride Augmentation Therapy Improves Cognitive Performance and Psychopathology in Clozapine-resistant Treatment-refractory Schizophrenia (CTRS): a 12-week Randomized, Double-blind, Placebo-controlled Trial

2022-01-03

Abstract excerpt

<h4>Background: </h4> Although clozapine is an effective option for treatment-resistant schizophrenia (TRS), there are still 1/3 to 1/2 of TRS patients who do not respond to clozapine. The main purposes of this randomized, double-blind, placebo-controlled trial was to explore the amisulpride augmentation efficacy on the psychopathological symptoms and cognitive function of CTRS patients. <h4>Methods: </h4> A total...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b9870292-8df8-5548-98f1-814074f3e8ef
DOI
10.21203/rs.3.rs-1213529/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Amisulpride Augmentation Therapy Improves Cognitive Performance and Psychopathology in Clozapine-resistant Treatment-refractory Schizophrenia (CTRS): a 12-week Randomized, Double-blind, Placebo-controlled TrialDOI 10.21203/rs.3.rs-1213529/v1
Antipsychotic Selection in Combination with Electroconvulsive Therapy for Acute Schizophrenia: Differential Efficacy and Safety Profiles from a Real World StudySemantic proximity
Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled studySemantic proximity
Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant SchizophreniaSemantic proximity
Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping ReviewSemantic proximity
Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene StudySemantic proximity
Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19Semantic proximity
Long-term Safety and Effectiveness of Lurasidone in Adolescents and Young Adults with Schizophrenia: Pooled Post hoc Analyses of Two 12-month Extension StudiesSemantic proximity
High-dose olanzapine for treatment-resistant schizophrenia.Semantic proximity
Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity
The Clinical Antipsychotic Effect of Recently Developed Antipsychotic Drugs in SchizophreniaSemantic proximity
Desloratadine Rescues Schizophrenia-like Phenotypes by Inhibiting the Pathogenic 5-HT2AR-PI3K/AKT/mTOR Signaling Axis.Semantic proximity
The role of antipsychotics and other drugs on the development and progression of Neuroleptic Malignant SyndromeSemantic proximity
Select a neighboring publication to make it the new centre.